Global Lung Cancer Genomic Testing Market Growth (Status and Outlook) 2026-2032
The global Lung Cancer Genomic Testing market size is predicted to grow from US$ 2942 million in 2025 to US$ 5467 million in 2032; it is expected to grow at a CAGR of 9.7% from 2026 to 2032.
Lung cancer genomic testing comprises clinical molecular diagnostic assays used to identify actionable genetic alterations in lung cancer patients to guide targeted therapy, immunotherapy selection, and disease monitoring. Commonly tested biomarkers include EGFR, ALK, ROS1, BRAF, KRAS, MET, RET, and NTRK, using PCR-based methods and next-generation sequencing (NGS) panels on tissue or liquid biopsy samples. From a value chain perspective, upstream inputs include sequencing platforms, reagents, probes, and bioinformatics infrastructure, midstream activities involve assay development, laboratory testing, quality control, and clinical interpretation, while downstream demand is driven by hospitals, oncology centers, pathology laboratories, and reference diagnostic labs.The industry maintains a 55%–75% gross margin, supported by high clinical value, reimbursement-backed demand, and increasing adoption of multi-gene profiling.
The market is rapidly shifting from single-gene assays to comprehensive NGS panels and liquid biopsy solutions. Competitive differentiation increasingly centers on panel breadth, turnaround time, companion diagnostic partnerships, and data interpretation capabilities rather than test price alone.
LPI (LP Information)' newest research report, the “Lung Cancer Genomic Testing Industry Forecast” looks at past sales and reviews total world Lung Cancer Genomic Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Lung Cancer Genomic Testing sales for 2026 through 2032. With Lung Cancer Genomic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lung Cancer Genomic Testing industry.
This Insight Report provides a comprehensive analysis of the global Lung Cancer Genomic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lung Cancer Genomic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lung Cancer Genomic Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lung Cancer Genomic Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lung Cancer Genomic Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Lung Cancer Genomic Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Lung cancer genomic testing comprises clinical molecular diagnostic assays used to identify actionable genetic alterations in lung cancer patients to guide targeted therapy, immunotherapy selection, and disease monitoring. Commonly tested biomarkers include EGFR, ALK, ROS1, BRAF, KRAS, MET, RET, and NTRK, using PCR-based methods and next-generation sequencing (NGS) panels on tissue or liquid biopsy samples. From a value chain perspective, upstream inputs include sequencing platforms, reagents, probes, and bioinformatics infrastructure, midstream activities involve assay development, laboratory testing, quality control, and clinical interpretation, while downstream demand is driven by hospitals, oncology centers, pathology laboratories, and reference diagnostic labs.The industry maintains a 55%–75% gross margin, supported by high clinical value, reimbursement-backed demand, and increasing adoption of multi-gene profiling.
The market is rapidly shifting from single-gene assays to comprehensive NGS panels and liquid biopsy solutions. Competitive differentiation increasingly centers on panel breadth, turnaround time, companion diagnostic partnerships, and data interpretation capabilities rather than test price alone.
LPI (LP Information)' newest research report, the “Lung Cancer Genomic Testing Industry Forecast” looks at past sales and reviews total world Lung Cancer Genomic Testing sales in 2025, providing a comprehensive analysis by region and market sector of projected Lung Cancer Genomic Testing sales for 2026 through 2032. With Lung Cancer Genomic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lung Cancer Genomic Testing industry.
This Insight Report provides a comprehensive analysis of the global Lung Cancer Genomic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Lung Cancer Genomic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lung Cancer Genomic Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lung Cancer Genomic Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lung Cancer Genomic Testing.
This report presents a comprehensive overview, market shares, and growth opportunities of Lung Cancer Genomic Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Liquid Biopsy
- Tissue Biopsy
- PCR-based Assays
- Next-generation Sequencing (NGS)
- Single-gene Testing
- Multi-gene Panel
- Comprehensive Genomic Profiling
- Hospitals/Clinics
- Research Organization
- Diagnostic Laboratories
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Roche
- Thermo Fisher Scientific
- Illumina
- Agilent Technologies
- QIAGEN
- Guardant Health
- Foundation Medicine
- BGI Genomics
- AmoyDx Diagnostics
- Burning Rock Dx
- Nanjing Geneseeq
- Berry Oncology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lung Cancer Genomic Testing Market Size (2021-2032)
2.1.2 Lung Cancer Genomic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Lung Cancer Genomic Testing by Country/Region (2021, 2025 & 2032)
2.2 Lung Cancer Genomic Testing Segment by Type
2.2.1 Liquid Biopsy
2.2.2 Tissue Biopsy
2.2.3 Lung Cancer Genomic Testing Market Size by Type
2.2.3.1 Lung Cancer Genomic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
2.3 Lung Cancer Genomic Testing Segment by Testing Technology
2.3.1 PCR-based Assays
2.3.2 Next-generation Sequencing (NGS)
2.3.3 Lung Cancer Genomic Testing Market Size by Testing Technology
2.3.3.1 Lung Cancer Genomic Testing Market Size CAGR by Testing Technology (2021 VS 2025 VS 2032)
2.3.3.2 Global Lung Cancer Genomic Testing Market Size Market Share by Testing Technology (2021-2026)
2.4 Lung Cancer Genomic Testing Segment by Gene Coverage
2.4.1 Single-gene Testing
2.4.2 Multi-gene Panel
2.4.3 Comprehensive Genomic Profiling
2.4.4 Lung Cancer Genomic Testing Market Size by Gene Coverage
2.4.4.1 Lung Cancer Genomic Testing Market Size CAGR by Gene Coverage (2021 VS 2025 VS 2032)
2.4.4.2 Global Lung Cancer Genomic Testing Market Size Market Share by Gene Coverage (2021-2026)
2.5 Lung Cancer Genomic Testing Segment by Application
2.5.1 Hospitals/Clinics
2.5.2 Research Organization
2.5.3 Diagnostic Laboratories
2.5.4 Lung Cancer Genomic Testing Market Size by Application
2.5.4.1 Lung Cancer Genomic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
3 LUNG CANCER GENOMIC TESTING MARKET SIZE BY PLAYER
3.1 Lung Cancer Genomic Testing Market Size Market Share by Player
3.1.1 Global Lung Cancer Genomic Testing Revenue by Player (2021-2026)
3.1.2 Global Lung Cancer Genomic Testing Revenue Market Share by Player (2021-2026)
3.2 Global Lung Cancer Genomic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LUNG CANCER GENOMIC TESTING BY REGION
4.1 Lung Cancer Genomic Testing Market Size by Region (2021-2026)
4.2 Global Lung Cancer Genomic Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lung Cancer Genomic Testing Market Size Growth (2021-2026)
4.4 APAC Lung Cancer Genomic Testing Market Size Growth (2021-2026)
4.5 Europe Lung Cancer Genomic Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Lung Cancer Genomic Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Lung Cancer Genomic Testing Market Size by Country (2021-2026)
5.2 Americas Lung Cancer Genomic Testing Market Size by Type (2021-2026)
5.3 Americas Lung Cancer Genomic Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Cancer Genomic Testing Market Size by Region (2021-2026)
6.2 APAC Lung Cancer Genomic Testing Market Size by Type (2021-2026)
6.3 APAC Lung Cancer Genomic Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Lung Cancer Genomic Testing Market Size by Country (2021-2026)
7.2 Europe Lung Cancer Genomic Testing Market Size by Type (2021-2026)
7.3 Europe Lung Cancer Genomic Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lung Cancer Genomic Testing by Region (2021-2026)
8.2 Middle East & Africa Lung Cancer Genomic Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Lung Cancer Genomic Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LUNG CANCER GENOMIC TESTING MARKET FORECAST
10.1 Global Lung Cancer Genomic Testing Forecast by Region (2027-2032)
10.1.1 Global Lung Cancer Genomic Testing Forecast by Region (2027-2032)
10.1.2 Americas Lung Cancer Genomic Testing Forecast
10.1.3 APAC Lung Cancer Genomic Testing Forecast
10.1.4 Europe Lung Cancer Genomic Testing Forecast
10.1.5 Middle East & Africa Lung Cancer Genomic Testing Forecast
10.2 Americas Lung Cancer Genomic Testing Forecast by Country (2027-2032)
10.2.1 United States Market Lung Cancer Genomic Testing Forecast
10.2.2 Canada Market Lung Cancer Genomic Testing Forecast
10.2.3 Mexico Market Lung Cancer Genomic Testing Forecast
10.2.4 Brazil Market Lung Cancer Genomic Testing Forecast
10.3 APAC Lung Cancer Genomic Testing Forecast by Region (2027-2032)
10.3.1 China Lung Cancer Genomic Testing Market Forecast
10.3.2 Japan Market Lung Cancer Genomic Testing Forecast
10.3.3 Korea Market Lung Cancer Genomic Testing Forecast
10.3.4 Southeast Asia Market Lung Cancer Genomic Testing Forecast
10.3.5 India Market Lung Cancer Genomic Testing Forecast
10.3.6 Australia Market Lung Cancer Genomic Testing Forecast
10.4 Europe Lung Cancer Genomic Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Lung Cancer Genomic Testing Forecast
10.4.2 France Market Lung Cancer Genomic Testing Forecast
10.4.3 UK Market Lung Cancer Genomic Testing Forecast
10.4.4 Italy Market Lung Cancer Genomic Testing Forecast
10.4.5 Russia Market Lung Cancer Genomic Testing Forecast
10.5 Middle East & Africa Lung Cancer Genomic Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Lung Cancer Genomic Testing Forecast
10.5.2 South Africa Market Lung Cancer Genomic Testing Forecast
10.5.3 Israel Market Lung Cancer Genomic Testing Forecast
10.5.4 Turkey Market Lung Cancer Genomic Testing Forecast
10.6 Global Lung Cancer Genomic Testing Forecast by Type (2027-2032)
10.7 Global Lung Cancer Genomic Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Lung Cancer Genomic Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Lung Cancer Genomic Testing Product Offered
11.1.3 Roche Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Lung Cancer Genomic Testing Product Offered
11.2.3 Thermo Fisher Scientific Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Lung Cancer Genomic Testing Product Offered
11.3.3 Illumina Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Information
11.4.2 Agilent Technologies Lung Cancer Genomic Testing Product Offered
11.4.3 Agilent Technologies Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Agilent Technologies Main Business Overview
11.4.5 Agilent Technologies Latest Developments
11.5 QIAGEN
11.5.1 QIAGEN Company Information
11.5.2 QIAGEN Lung Cancer Genomic Testing Product Offered
11.5.3 QIAGEN Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 QIAGEN Main Business Overview
11.5.5 QIAGEN Latest Developments
11.6 Guardant Health
11.6.1 Guardant Health Company Information
11.6.2 Guardant Health Lung Cancer Genomic Testing Product Offered
11.6.3 Guardant Health Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Guardant Health Main Business Overview
11.6.5 Guardant Health Latest Developments
11.7 Foundation Medicine
11.7.1 Foundation Medicine Company Information
11.7.2 Foundation Medicine Lung Cancer Genomic Testing Product Offered
11.7.3 Foundation Medicine Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Foundation Medicine Main Business Overview
11.7.5 Foundation Medicine Latest Developments
11.8 BGI Genomics
11.8.1 BGI Genomics Company Information
11.8.2 BGI Genomics Lung Cancer Genomic Testing Product Offered
11.8.3 BGI Genomics Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BGI Genomics Main Business Overview
11.8.5 BGI Genomics Latest Developments
11.9 AmoyDx Diagnostics
11.9.1 AmoyDx Diagnostics Company Information
11.9.2 AmoyDx Diagnostics Lung Cancer Genomic Testing Product Offered
11.9.3 AmoyDx Diagnostics Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 AmoyDx Diagnostics Main Business Overview
11.9.5 AmoyDx Diagnostics Latest Developments
11.10 Burning Rock Dx
11.10.1 Burning Rock Dx Company Information
11.10.2 Burning Rock Dx Lung Cancer Genomic Testing Product Offered
11.10.3 Burning Rock Dx Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Burning Rock Dx Main Business Overview
11.10.5 Burning Rock Dx Latest Developments
11.11 Nanjing Geneseeq
11.11.1 Nanjing Geneseeq Company Information
11.11.2 Nanjing Geneseeq Lung Cancer Genomic Testing Product Offered
11.11.3 Nanjing Geneseeq Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Nanjing Geneseeq Main Business Overview
11.11.5 Nanjing Geneseeq Latest Developments
11.12 Berry Oncology
11.12.1 Berry Oncology Company Information
11.12.2 Berry Oncology Lung Cancer Genomic Testing Product Offered
11.12.3 Berry Oncology Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Berry Oncology Main Business Overview
11.12.5 Berry Oncology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lung Cancer Genomic Testing Market Size (2021-2032)
2.1.2 Lung Cancer Genomic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Lung Cancer Genomic Testing by Country/Region (2021, 2025 & 2032)
2.2 Lung Cancer Genomic Testing Segment by Type
2.2.1 Liquid Biopsy
2.2.2 Tissue Biopsy
2.2.3 Lung Cancer Genomic Testing Market Size by Type
2.2.3.1 Lung Cancer Genomic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
2.3 Lung Cancer Genomic Testing Segment by Testing Technology
2.3.1 PCR-based Assays
2.3.2 Next-generation Sequencing (NGS)
2.3.3 Lung Cancer Genomic Testing Market Size by Testing Technology
2.3.3.1 Lung Cancer Genomic Testing Market Size CAGR by Testing Technology (2021 VS 2025 VS 2032)
2.3.3.2 Global Lung Cancer Genomic Testing Market Size Market Share by Testing Technology (2021-2026)
2.4 Lung Cancer Genomic Testing Segment by Gene Coverage
2.4.1 Single-gene Testing
2.4.2 Multi-gene Panel
2.4.3 Comprehensive Genomic Profiling
2.4.4 Lung Cancer Genomic Testing Market Size by Gene Coverage
2.4.4.1 Lung Cancer Genomic Testing Market Size CAGR by Gene Coverage (2021 VS 2025 VS 2032)
2.4.4.2 Global Lung Cancer Genomic Testing Market Size Market Share by Gene Coverage (2021-2026)
2.5 Lung Cancer Genomic Testing Segment by Application
2.5.1 Hospitals/Clinics
2.5.2 Research Organization
2.5.3 Diagnostic Laboratories
2.5.4 Lung Cancer Genomic Testing Market Size by Application
2.5.4.1 Lung Cancer Genomic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
3 LUNG CANCER GENOMIC TESTING MARKET SIZE BY PLAYER
3.1 Lung Cancer Genomic Testing Market Size Market Share by Player
3.1.1 Global Lung Cancer Genomic Testing Revenue by Player (2021-2026)
3.1.2 Global Lung Cancer Genomic Testing Revenue Market Share by Player (2021-2026)
3.2 Global Lung Cancer Genomic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LUNG CANCER GENOMIC TESTING BY REGION
4.1 Lung Cancer Genomic Testing Market Size by Region (2021-2026)
4.2 Global Lung Cancer Genomic Testing Annual Revenue by Country/Region (2021-2026)
4.3 Americas Lung Cancer Genomic Testing Market Size Growth (2021-2026)
4.4 APAC Lung Cancer Genomic Testing Market Size Growth (2021-2026)
4.5 Europe Lung Cancer Genomic Testing Market Size Growth (2021-2026)
4.6 Middle East & Africa Lung Cancer Genomic Testing Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Lung Cancer Genomic Testing Market Size by Country (2021-2026)
5.2 Americas Lung Cancer Genomic Testing Market Size by Type (2021-2026)
5.3 Americas Lung Cancer Genomic Testing Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lung Cancer Genomic Testing Market Size by Region (2021-2026)
6.2 APAC Lung Cancer Genomic Testing Market Size by Type (2021-2026)
6.3 APAC Lung Cancer Genomic Testing Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Lung Cancer Genomic Testing Market Size by Country (2021-2026)
7.2 Europe Lung Cancer Genomic Testing Market Size by Type (2021-2026)
7.3 Europe Lung Cancer Genomic Testing Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lung Cancer Genomic Testing by Region (2021-2026)
8.2 Middle East & Africa Lung Cancer Genomic Testing Market Size by Type (2021-2026)
8.3 Middle East & Africa Lung Cancer Genomic Testing Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LUNG CANCER GENOMIC TESTING MARKET FORECAST
10.1 Global Lung Cancer Genomic Testing Forecast by Region (2027-2032)
10.1.1 Global Lung Cancer Genomic Testing Forecast by Region (2027-2032)
10.1.2 Americas Lung Cancer Genomic Testing Forecast
10.1.3 APAC Lung Cancer Genomic Testing Forecast
10.1.4 Europe Lung Cancer Genomic Testing Forecast
10.1.5 Middle East & Africa Lung Cancer Genomic Testing Forecast
10.2 Americas Lung Cancer Genomic Testing Forecast by Country (2027-2032)
10.2.1 United States Market Lung Cancer Genomic Testing Forecast
10.2.2 Canada Market Lung Cancer Genomic Testing Forecast
10.2.3 Mexico Market Lung Cancer Genomic Testing Forecast
10.2.4 Brazil Market Lung Cancer Genomic Testing Forecast
10.3 APAC Lung Cancer Genomic Testing Forecast by Region (2027-2032)
10.3.1 China Lung Cancer Genomic Testing Market Forecast
10.3.2 Japan Market Lung Cancer Genomic Testing Forecast
10.3.3 Korea Market Lung Cancer Genomic Testing Forecast
10.3.4 Southeast Asia Market Lung Cancer Genomic Testing Forecast
10.3.5 India Market Lung Cancer Genomic Testing Forecast
10.3.6 Australia Market Lung Cancer Genomic Testing Forecast
10.4 Europe Lung Cancer Genomic Testing Forecast by Country (2027-2032)
10.4.1 Germany Market Lung Cancer Genomic Testing Forecast
10.4.2 France Market Lung Cancer Genomic Testing Forecast
10.4.3 UK Market Lung Cancer Genomic Testing Forecast
10.4.4 Italy Market Lung Cancer Genomic Testing Forecast
10.4.5 Russia Market Lung Cancer Genomic Testing Forecast
10.5 Middle East & Africa Lung Cancer Genomic Testing Forecast by Region (2027-2032)
10.5.1 Egypt Market Lung Cancer Genomic Testing Forecast
10.5.2 South Africa Market Lung Cancer Genomic Testing Forecast
10.5.3 Israel Market Lung Cancer Genomic Testing Forecast
10.5.4 Turkey Market Lung Cancer Genomic Testing Forecast
10.6 Global Lung Cancer Genomic Testing Forecast by Type (2027-2032)
10.7 Global Lung Cancer Genomic Testing Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Lung Cancer Genomic Testing Forecast
11 KEY PLAYERS ANALYSIS
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Lung Cancer Genomic Testing Product Offered
11.1.3 Roche Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Lung Cancer Genomic Testing Product Offered
11.2.3 Thermo Fisher Scientific Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Illumina
11.3.1 Illumina Company Information
11.3.2 Illumina Lung Cancer Genomic Testing Product Offered
11.3.3 Illumina Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Illumina Main Business Overview
11.3.5 Illumina Latest Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Information
11.4.2 Agilent Technologies Lung Cancer Genomic Testing Product Offered
11.4.3 Agilent Technologies Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Agilent Technologies Main Business Overview
11.4.5 Agilent Technologies Latest Developments
11.5 QIAGEN
11.5.1 QIAGEN Company Information
11.5.2 QIAGEN Lung Cancer Genomic Testing Product Offered
11.5.3 QIAGEN Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 QIAGEN Main Business Overview
11.5.5 QIAGEN Latest Developments
11.6 Guardant Health
11.6.1 Guardant Health Company Information
11.6.2 Guardant Health Lung Cancer Genomic Testing Product Offered
11.6.3 Guardant Health Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Guardant Health Main Business Overview
11.6.5 Guardant Health Latest Developments
11.7 Foundation Medicine
11.7.1 Foundation Medicine Company Information
11.7.2 Foundation Medicine Lung Cancer Genomic Testing Product Offered
11.7.3 Foundation Medicine Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Foundation Medicine Main Business Overview
11.7.5 Foundation Medicine Latest Developments
11.8 BGI Genomics
11.8.1 BGI Genomics Company Information
11.8.2 BGI Genomics Lung Cancer Genomic Testing Product Offered
11.8.3 BGI Genomics Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 BGI Genomics Main Business Overview
11.8.5 BGI Genomics Latest Developments
11.9 AmoyDx Diagnostics
11.9.1 AmoyDx Diagnostics Company Information
11.9.2 AmoyDx Diagnostics Lung Cancer Genomic Testing Product Offered
11.9.3 AmoyDx Diagnostics Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 AmoyDx Diagnostics Main Business Overview
11.9.5 AmoyDx Diagnostics Latest Developments
11.10 Burning Rock Dx
11.10.1 Burning Rock Dx Company Information
11.10.2 Burning Rock Dx Lung Cancer Genomic Testing Product Offered
11.10.3 Burning Rock Dx Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Burning Rock Dx Main Business Overview
11.10.5 Burning Rock Dx Latest Developments
11.11 Nanjing Geneseeq
11.11.1 Nanjing Geneseeq Company Information
11.11.2 Nanjing Geneseeq Lung Cancer Genomic Testing Product Offered
11.11.3 Nanjing Geneseeq Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Nanjing Geneseeq Main Business Overview
11.11.5 Nanjing Geneseeq Latest Developments
11.12 Berry Oncology
11.12.1 Berry Oncology Company Information
11.12.2 Berry Oncology Lung Cancer Genomic Testing Product Offered
11.12.3 Berry Oncology Lung Cancer Genomic Testing Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Berry Oncology Main Business Overview
11.12.5 Berry Oncology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lung Cancer Genomic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Lung Cancer Genomic Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liquid Biopsy
Table 4. Major Players of Tissue Biopsy
Table 5. Lung Cancer Genomic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Lung Cancer Genomic Testing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
Table 8. Major Players of PCR-based Assays
Table 9. Major Players of Next-generation Sequencing (NGS)
Table 10. Lung Cancer Genomic Testing Market Size CAGR by Testing Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Lung Cancer Genomic Testing Market Size by Testing Technology (2021-2026) & ($ millions)
Table 12. Global Lung Cancer Genomic Testing Market Size Market Share by Testing Technology (2021-2026)
Table 13. Major Players of Single-gene Testing
Table 14. Major Players of Multi-gene Panel
Table 15. Major Players of Comprehensive Genomic Profiling
Table 16. Lung Cancer Genomic Testing Market Size CAGR by Gene Coverage (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Lung Cancer Genomic Testing Market Size by Gene Coverage (2021-2026) & ($ millions)
Table 18. Global Lung Cancer Genomic Testing Market Size Market Share by Gene Coverage (2021-2026)
Table 19. Lung Cancer Genomic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Lung Cancer Genomic Testing Market Size by Application (2021-2026) & ($ millions)
Table 21. Global Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
Table 22. Global Lung Cancer Genomic Testing Revenue by Player (2021-2026) & ($ millions)
Table 23. Global Lung Cancer Genomic Testing Revenue Market Share by Player (2021-2026)
Table 24. Lung Cancer Genomic Testing Key Players Head office and Products Offered
Table 25. Lung Cancer Genomic Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Lung Cancer Genomic Testing Market Size by Region (2021-2026) & ($ millions)
Table 29. Global Lung Cancer Genomic Testing Market Size Market Share by Region (2021-2026)
Table 30. Global Lung Cancer Genomic Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 31. Global Lung Cancer Genomic Testing Revenue Market Share by Country/Region (2021-2026)
Table 32. Americas Lung Cancer Genomic Testing Market Size by Country (2021-2026) & ($ millions)
Table 33. Americas Lung Cancer Genomic Testing Market Size Market Share by Country (2021-2026)
Table 34. Americas Lung Cancer Genomic Testing Market Size by Type (2021-2026) & ($ millions)
Table 35. Americas Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
Table 36. Americas Lung Cancer Genomic Testing Market Size by Application (2021-2026) & ($ millions)
Table 37. Americas Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
Table 38. APAC Lung Cancer Genomic Testing Market Size by Region (2021-2026) & ($ millions)
Table 39. APAC Lung Cancer Genomic Testing Market Size Market Share by Region (2021-2026)
Table 40. APAC Lung Cancer Genomic Testing Market Size by Type (2021-2026) & ($ millions)
Table 41. APAC Lung Cancer Genomic Testing Market Size by Application (2021-2026) & ($ millions)
Table 42. Europe Lung Cancer Genomic Testing Market Size by Country (2021-2026) & ($ millions)
Table 43. Europe Lung Cancer Genomic Testing Market Size Market Share by Country (2021-2026)
Table 44. Europe Lung Cancer Genomic Testing Market Size by Type (2021-2026) & ($ millions)
Table 45. Europe Lung Cancer Genomic Testing Market Size by Application (2021-2026) & ($ millions)
Table 46. Middle East & Africa Lung Cancer Genomic Testing Market Size by Region (2021-2026) & ($ millions)
Table 47. Middle East & Africa Lung Cancer Genomic Testing Market Size by Type (2021-2026) & ($ millions)
Table 48. Middle East & Africa Lung Cancer Genomic Testing Market Size by Application (2021-2026) & ($ millions)
Table 49. Key Market Drivers & Growth Opportunities of Lung Cancer Genomic Testing
Table 50. Key Market Challenges & Risks of Lung Cancer Genomic Testing
Table 51. Key Industry Trends of Lung Cancer Genomic Testing
Table 52. Global Lung Cancer Genomic Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 53. Global Lung Cancer Genomic Testing Market Size Market Share Forecast by Region (2027-2032)
Table 54. Global Lung Cancer Genomic Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 55. Global Lung Cancer Genomic Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 56. Roche Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 57. Roche Lung Cancer Genomic Testing Product Offered
Table 58. Roche Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Roche Main Business
Table 60. Roche Latest Developments
Table 61. Thermo Fisher Scientific Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 62. Thermo Fisher Scientific Lung Cancer Genomic Testing Product Offered
Table 63. Thermo Fisher Scientific Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Thermo Fisher Scientific Main Business
Table 65. Thermo Fisher Scientific Latest Developments
Table 66. Illumina Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 67. Illumina Lung Cancer Genomic Testing Product Offered
Table 68. Illumina Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Illumina Main Business
Table 70. Illumina Latest Developments
Table 71. Agilent Technologies Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 72. Agilent Technologies Lung Cancer Genomic Testing Product Offered
Table 73. Agilent Technologies Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Agilent Technologies Main Business
Table 75. Agilent Technologies Latest Developments
Table 76. QIAGEN Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 77. QIAGEN Lung Cancer Genomic Testing Product Offered
Table 78. QIAGEN Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. QIAGEN Main Business
Table 80. QIAGEN Latest Developments
Table 81. Guardant Health Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 82. Guardant Health Lung Cancer Genomic Testing Product Offered
Table 83. Guardant Health Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Guardant Health Main Business
Table 85. Guardant Health Latest Developments
Table 86. Foundation Medicine Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 87. Foundation Medicine Lung Cancer Genomic Testing Product Offered
Table 88. Foundation Medicine Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Foundation Medicine Main Business
Table 90. Foundation Medicine Latest Developments
Table 91. BGI Genomics Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 92. BGI Genomics Lung Cancer Genomic Testing Product Offered
Table 93. BGI Genomics Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. BGI Genomics Main Business
Table 95. BGI Genomics Latest Developments
Table 96. AmoyDx Diagnostics Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 97. AmoyDx Diagnostics Lung Cancer Genomic Testing Product Offered
Table 98. AmoyDx Diagnostics Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. AmoyDx Diagnostics Main Business
Table 100. AmoyDx Diagnostics Latest Developments
Table 101. Burning Rock Dx Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 102. Burning Rock Dx Lung Cancer Genomic Testing Product Offered
Table 103. Burning Rock Dx Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Burning Rock Dx Main Business
Table 105. Burning Rock Dx Latest Developments
Table 106. Nanjing Geneseeq Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 107. Nanjing Geneseeq Lung Cancer Genomic Testing Product Offered
Table 108. Nanjing Geneseeq Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Nanjing Geneseeq Main Business
Table 110. Nanjing Geneseeq Latest Developments
Table 111. Berry Oncology Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 112. Berry Oncology Lung Cancer Genomic Testing Product Offered
Table 113. Berry Oncology Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Berry Oncology Main Business
Table 115. Berry Oncology Latest Developments
Table 1. Lung Cancer Genomic Testing Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Lung Cancer Genomic Testing Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Liquid Biopsy
Table 4. Major Players of Tissue Biopsy
Table 5. Lung Cancer Genomic Testing Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Lung Cancer Genomic Testing Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
Table 8. Major Players of PCR-based Assays
Table 9. Major Players of Next-generation Sequencing (NGS)
Table 10. Lung Cancer Genomic Testing Market Size CAGR by Testing Technology (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Lung Cancer Genomic Testing Market Size by Testing Technology (2021-2026) & ($ millions)
Table 12. Global Lung Cancer Genomic Testing Market Size Market Share by Testing Technology (2021-2026)
Table 13. Major Players of Single-gene Testing
Table 14. Major Players of Multi-gene Panel
Table 15. Major Players of Comprehensive Genomic Profiling
Table 16. Lung Cancer Genomic Testing Market Size CAGR by Gene Coverage (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global Lung Cancer Genomic Testing Market Size by Gene Coverage (2021-2026) & ($ millions)
Table 18. Global Lung Cancer Genomic Testing Market Size Market Share by Gene Coverage (2021-2026)
Table 19. Lung Cancer Genomic Testing Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global Lung Cancer Genomic Testing Market Size by Application (2021-2026) & ($ millions)
Table 21. Global Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
Table 22. Global Lung Cancer Genomic Testing Revenue by Player (2021-2026) & ($ millions)
Table 23. Global Lung Cancer Genomic Testing Revenue Market Share by Player (2021-2026)
Table 24. Lung Cancer Genomic Testing Key Players Head office and Products Offered
Table 25. Lung Cancer Genomic Testing Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Lung Cancer Genomic Testing Market Size by Region (2021-2026) & ($ millions)
Table 29. Global Lung Cancer Genomic Testing Market Size Market Share by Region (2021-2026)
Table 30. Global Lung Cancer Genomic Testing Revenue by Country/Region (2021-2026) & ($ millions)
Table 31. Global Lung Cancer Genomic Testing Revenue Market Share by Country/Region (2021-2026)
Table 32. Americas Lung Cancer Genomic Testing Market Size by Country (2021-2026) & ($ millions)
Table 33. Americas Lung Cancer Genomic Testing Market Size Market Share by Country (2021-2026)
Table 34. Americas Lung Cancer Genomic Testing Market Size by Type (2021-2026) & ($ millions)
Table 35. Americas Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
Table 36. Americas Lung Cancer Genomic Testing Market Size by Application (2021-2026) & ($ millions)
Table 37. Americas Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
Table 38. APAC Lung Cancer Genomic Testing Market Size by Region (2021-2026) & ($ millions)
Table 39. APAC Lung Cancer Genomic Testing Market Size Market Share by Region (2021-2026)
Table 40. APAC Lung Cancer Genomic Testing Market Size by Type (2021-2026) & ($ millions)
Table 41. APAC Lung Cancer Genomic Testing Market Size by Application (2021-2026) & ($ millions)
Table 42. Europe Lung Cancer Genomic Testing Market Size by Country (2021-2026) & ($ millions)
Table 43. Europe Lung Cancer Genomic Testing Market Size Market Share by Country (2021-2026)
Table 44. Europe Lung Cancer Genomic Testing Market Size by Type (2021-2026) & ($ millions)
Table 45. Europe Lung Cancer Genomic Testing Market Size by Application (2021-2026) & ($ millions)
Table 46. Middle East & Africa Lung Cancer Genomic Testing Market Size by Region (2021-2026) & ($ millions)
Table 47. Middle East & Africa Lung Cancer Genomic Testing Market Size by Type (2021-2026) & ($ millions)
Table 48. Middle East & Africa Lung Cancer Genomic Testing Market Size by Application (2021-2026) & ($ millions)
Table 49. Key Market Drivers & Growth Opportunities of Lung Cancer Genomic Testing
Table 50. Key Market Challenges & Risks of Lung Cancer Genomic Testing
Table 51. Key Industry Trends of Lung Cancer Genomic Testing
Table 52. Global Lung Cancer Genomic Testing Market Size Forecast by Region (2027-2032) & ($ millions)
Table 53. Global Lung Cancer Genomic Testing Market Size Market Share Forecast by Region (2027-2032)
Table 54. Global Lung Cancer Genomic Testing Market Size Forecast by Type (2027-2032) & ($ millions)
Table 55. Global Lung Cancer Genomic Testing Market Size Forecast by Application (2027-2032) & ($ millions)
Table 56. Roche Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 57. Roche Lung Cancer Genomic Testing Product Offered
Table 58. Roche Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Roche Main Business
Table 60. Roche Latest Developments
Table 61. Thermo Fisher Scientific Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 62. Thermo Fisher Scientific Lung Cancer Genomic Testing Product Offered
Table 63. Thermo Fisher Scientific Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Thermo Fisher Scientific Main Business
Table 65. Thermo Fisher Scientific Latest Developments
Table 66. Illumina Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 67. Illumina Lung Cancer Genomic Testing Product Offered
Table 68. Illumina Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Illumina Main Business
Table 70. Illumina Latest Developments
Table 71. Agilent Technologies Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 72. Agilent Technologies Lung Cancer Genomic Testing Product Offered
Table 73. Agilent Technologies Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Agilent Technologies Main Business
Table 75. Agilent Technologies Latest Developments
Table 76. QIAGEN Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 77. QIAGEN Lung Cancer Genomic Testing Product Offered
Table 78. QIAGEN Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. QIAGEN Main Business
Table 80. QIAGEN Latest Developments
Table 81. Guardant Health Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 82. Guardant Health Lung Cancer Genomic Testing Product Offered
Table 83. Guardant Health Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Guardant Health Main Business
Table 85. Guardant Health Latest Developments
Table 86. Foundation Medicine Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 87. Foundation Medicine Lung Cancer Genomic Testing Product Offered
Table 88. Foundation Medicine Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Foundation Medicine Main Business
Table 90. Foundation Medicine Latest Developments
Table 91. BGI Genomics Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 92. BGI Genomics Lung Cancer Genomic Testing Product Offered
Table 93. BGI Genomics Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. BGI Genomics Main Business
Table 95. BGI Genomics Latest Developments
Table 96. AmoyDx Diagnostics Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 97. AmoyDx Diagnostics Lung Cancer Genomic Testing Product Offered
Table 98. AmoyDx Diagnostics Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. AmoyDx Diagnostics Main Business
Table 100. AmoyDx Diagnostics Latest Developments
Table 101. Burning Rock Dx Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 102. Burning Rock Dx Lung Cancer Genomic Testing Product Offered
Table 103. Burning Rock Dx Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Burning Rock Dx Main Business
Table 105. Burning Rock Dx Latest Developments
Table 106. Nanjing Geneseeq Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 107. Nanjing Geneseeq Lung Cancer Genomic Testing Product Offered
Table 108. Nanjing Geneseeq Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Nanjing Geneseeq Main Business
Table 110. Nanjing Geneseeq Latest Developments
Table 111. Berry Oncology Details, Company Type, Lung Cancer Genomic Testing Area Served and Its Competitors
Table 112. Berry Oncology Lung Cancer Genomic Testing Product Offered
Table 113. Berry Oncology Lung Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Berry Oncology Main Business
Table 115. Berry Oncology Latest Developments
LIST OF FIGURES
Figure 1. Lung Cancer Genomic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lung Cancer Genomic Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Lung Cancer Genomic Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Lung Cancer Genomic Testing Sales Market Share by Country/Region (2025)
Figure 8. Lung Cancer Genomic Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Lung Cancer Genomic Testing Market Size Market Share by Type in 2025
Figure 10. Global Lung Cancer Genomic Testing Market Size Market Share by Testing Technology in 2025
Figure 11. Global Lung Cancer Genomic Testing Market Size Market Share by Gene Coverage in 2025
Figure 12. Lung Cancer Genomic Testing in Hospitals/Clinics
Figure 13. Global Lung Cancer Genomic Testing Market: Hospitals/Clinics (2021-2026) & ($ millions)
Figure 14. Lung Cancer Genomic Testing in Research Organization
Figure 15. Global Lung Cancer Genomic Testing Market: Research Organization (2021-2026) & ($ millions)
Figure 16. Lung Cancer Genomic Testing in Diagnostic Laboratories
Figure 17. Global Lung Cancer Genomic Testing Market: Diagnostic Laboratories (2021-2026) & ($ millions)
Figure 18. Global Lung Cancer Genomic Testing Market Size Market Share by Application in 2025
Figure 19. Global Lung Cancer Genomic Testing Revenue Market Share by Player in 2025
Figure 20. Global Lung Cancer Genomic Testing Market Size Market Share by Region (2021-2026)
Figure 21. Americas Lung Cancer Genomic Testing Market Size 2021-2026 ($ millions)
Figure 22. APAC Lung Cancer Genomic Testing Market Size 2021-2026 ($ millions)
Figure 23. Europe Lung Cancer Genomic Testing Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Lung Cancer Genomic Testing Market Size 2021-2026 ($ millions)
Figure 25. Americas Lung Cancer Genomic Testing Value Market Share by Country in 2025
Figure 26. United States Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Lung Cancer Genomic Testing Market Size Market Share by Region in 2025
Figure 31. APAC Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
Figure 32. APAC Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
Figure 33. China Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. India Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Lung Cancer Genomic Testing Market Size Market Share by Country in 2025
Figure 40. Europe Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
Figure 41. Europe Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
Figure 42. Germany Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. France Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Lung Cancer Genomic Testing Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 56. APAC Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 57. Europe Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 59. United States Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 60. Canada Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 61. Mexico Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 62. Brazil Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 63. China Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 64. Japan Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 65. Korea Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 67. India Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 68. Australia Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 69. Germany Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 70. France Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 71. UK Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 72. Italy Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 73. Russia Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 74. Egypt Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 75. South Africa Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 76. Israel Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 77. Turkey Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 78. Global Lung Cancer Genomic Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Lung Cancer Genomic Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 1. Lung Cancer Genomic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lung Cancer Genomic Testing Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Lung Cancer Genomic Testing Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Lung Cancer Genomic Testing Sales Market Share by Country/Region (2025)
Figure 8. Lung Cancer Genomic Testing Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Lung Cancer Genomic Testing Market Size Market Share by Type in 2025
Figure 10. Global Lung Cancer Genomic Testing Market Size Market Share by Testing Technology in 2025
Figure 11. Global Lung Cancer Genomic Testing Market Size Market Share by Gene Coverage in 2025
Figure 12. Lung Cancer Genomic Testing in Hospitals/Clinics
Figure 13. Global Lung Cancer Genomic Testing Market: Hospitals/Clinics (2021-2026) & ($ millions)
Figure 14. Lung Cancer Genomic Testing in Research Organization
Figure 15. Global Lung Cancer Genomic Testing Market: Research Organization (2021-2026) & ($ millions)
Figure 16. Lung Cancer Genomic Testing in Diagnostic Laboratories
Figure 17. Global Lung Cancer Genomic Testing Market: Diagnostic Laboratories (2021-2026) & ($ millions)
Figure 18. Global Lung Cancer Genomic Testing Market Size Market Share by Application in 2025
Figure 19. Global Lung Cancer Genomic Testing Revenue Market Share by Player in 2025
Figure 20. Global Lung Cancer Genomic Testing Market Size Market Share by Region (2021-2026)
Figure 21. Americas Lung Cancer Genomic Testing Market Size 2021-2026 ($ millions)
Figure 22. APAC Lung Cancer Genomic Testing Market Size 2021-2026 ($ millions)
Figure 23. Europe Lung Cancer Genomic Testing Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Lung Cancer Genomic Testing Market Size 2021-2026 ($ millions)
Figure 25. Americas Lung Cancer Genomic Testing Value Market Share by Country in 2025
Figure 26. United States Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Lung Cancer Genomic Testing Market Size Market Share by Region in 2025
Figure 31. APAC Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
Figure 32. APAC Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
Figure 33. China Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 37. India Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Lung Cancer Genomic Testing Market Size Market Share by Country in 2025
Figure 40. Europe Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
Figure 41. Europe Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
Figure 42. Germany Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 43. France Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Lung Cancer Genomic Testing Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Lung Cancer Genomic Testing Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Lung Cancer Genomic Testing Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Lung Cancer Genomic Testing Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 56. APAC Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 57. Europe Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 59. United States Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 60. Canada Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 61. Mexico Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 62. Brazil Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 63. China Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 64. Japan Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 65. Korea Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 67. India Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 68. Australia Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 69. Germany Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 70. France Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 71. UK Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 72. Italy Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 73. Russia Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 74. Egypt Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 75. South Africa Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 76. Israel Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 77. Turkey Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
Figure 78. Global Lung Cancer Genomic Testing Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Lung Cancer Genomic Testing Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Lung Cancer Genomic Testing Market Size 2027-2032 ($ millions)
